statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	28.935
EU - Europa	15.044
AS - Asia	8.482
SA - Sud America	1.320
AF - Africa	119
Continente sconosciuto - Info sul continente non disponibili	37
OC - Oceania	15
Totale	53.952

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	28.663
IT - Italia	7.097
SG - Singapore	2.888
UA - Ucraina	2.295
TR - Turchia	1.648
HK - Hong Kong	1.259
SE - Svezia	1.223
DE - Germania	1.168
CN - Cina	1.143
BR - Brasile	1.115
VN - Vietnam	1.035
IE - Irlanda	802
FI - Finlandia	687
GB - Regno Unito	634
RU - Federazione Russa	499
FR - Francia	221
CA - Canada	156
IN - India	145
MX - Messico	91
AR - Argentina	79
JP - Giappone	79
NL - Olanda	73
PL - Polonia	64
AT - Austria	61
BD - Bangladesh	60
ES - Italia	57
ZA - Sudafrica	52
IQ - Iraq	36
LT - Lituania	36
BE - Belgio	34
EU - Europa	29
EC - Ecuador	24
CL - Cile	22
CZ - Repubblica Ceca	20
IL - Israele	20
MA - Marocco	20
PK - Pakistan	20
ID - Indonesia	19
VE - Venezuela	19
PY - Paraguay	17
UZ - Uzbekistan	17
CO - Colombia	16
AE - Emirati Arabi Uniti	14
AU - Australia	14
SA - Arabia Saudita	13
KE - Kenya	12
CH - Svizzera	11
JO - Giordania	11
PE - Perù	11
UY - Uruguay	11
EG - Egitto	10
IR - Iran	9
PT - Portogallo	9
RO - Romania	9
AZ - Azerbaigian	8
GR - Grecia	8
MY - Malesia	7
PH - Filippine	7
AL - Albania	6
BO - Bolivia	6
CI - Costa d'Avorio	6
RS - Serbia	6
DZ - Algeria	5
HN - Honduras	5
LB - Libano	5
TW - Taiwan	5
DO - Repubblica Dominicana	4
HU - Ungheria	4
KR - Corea	4
KW - Kuwait	4
KZ - Kazakistan	4
TH - Thailandia	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
DK - Danimarca	3
ET - Etiopia	3
MK - Macedonia	3
NG - Nigeria	3
NO - Norvegia	3
NP - Nepal	3
OM - Oman	3
TT - Trinidad e Tobago	3
AM - Armenia	2
AO - Angola	2
BA - Bosnia-Erzegovina	2
CR - Costa Rica	2
DM - Dominica	2
GT - Guatemala	2
JM - Giamaica	2
LI - Liechtenstein	2
LK - Sri Lanka	2
MD - Moldavia	2
PA - Panama	2
PS - Palestinian Territory	2
SI - Slovenia	2
SN - Senegal	2
SV - El Salvador	2
TN - Tunisia	2
A1 - Anonimo	1
BH - Bahrain	1
Totale	53.940

Salva come PNG Salva come JPEG

Città	#
Milan	5.039
Fairfield	4.108
Woodbridge	2.671
Ashburn	2.396
Houston	1.944
Jacksonville	1.808
Seattle	1.608
Singapore	1.524
Wilmington	1.505
Chandler	1.387
Cambridge	1.385
Ann Arbor	1.312
Hong Kong	1.254
Dallas	866
Izmir	815
Dublin	796
Princeton	787
Dearborn	591
Nyköping	539
Boardman	502
Beijing	412
The Dalles	384
Dong Ket	367
Rome	330
Munich	300
Los Angeles	246
San Diego	244
Chicago	234
New York	207
London	190
Helsinki	167
San Mateo	159
Ogden	152
Como	127
São Paulo	124
Santa Clara	121
Ho Chi Minh City	118
Washington	105
Nuremberg	74
Düsseldorf	71
Tokyo	67
Hefei	63
Montreal	63
Redmond	62
Hanoi	59
Nanjing	59
Buffalo	57
Turku	55
Norwalk	53
Verona	53
Kunming	52
Warsaw	51
Brooklyn	50
Mexico City	50
Salt Lake City	47
Denver	43
Phoenix	43
Frankfurt am Main	41
Chennai	40
Paris	40
Atlanta	39
Kocaeli	39
Toronto	39
Stockholm	38
Rio de Janeiro	36
San Francisco	36
Varese	36
Boston	35
Johannesburg	35
Belo Horizonte	33
Orem	33
Jinan	30
Kilburn	30
Amsterdam	29
Brussels	29
Columbus	27
Council Bluffs	27
Poplar	27
Tampa	27
Guangzhou	25
Elk Grove Village	24
Nanchang	24
Manchester	23
Vienna	22
Besana In Brianza	20
Falkenstein	20
Falls Church	19
Ponte Lambro	19
Redwood City	19
Ankara	18
Prescot	18
Fuzhou	17
Haiphong	17
Miami	17
Mumbai	17
Philadelphia	17
Brasília	16
Chiswick	16
Curitiba	16
Shanghai	16
Totale	39.042

Salva come PNG Salva come JPEG

Nome	#
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	357
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	318
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	300
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	293
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	278
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	259
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	247
Risk of recurrence of unusual site venous thromboembolism	231
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	231
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	231
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	231
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	226
ABO blood group and vascular disease: an update	226
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	223
Optimal treatment duration of venous thrombosis	220
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	219
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	214
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	213
Venous ischemic syndromes	213
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	211
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	211
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	210
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	209
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	208
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	208
Patient selection for thromboprophylaxis in medical inpatients	205
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	202
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	202
Warfarin interactions with antibiotics in the ambulatory care setting	199
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	198
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	196
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	195
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	195
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	194
Venous and arterial thrombosis in patients with HIV infection	193
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	193
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	191
Abdominal obesity and the risk of recurrent deep vein thrombosis.	190
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	190
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	189
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	189
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	189
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	188
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	187
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	187
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	187
Seasonal and monthly variation in occurrence of hypertensive urgency	185
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	185
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	184
Duration of anticoagulation after venous thromboembolism in real world clinical practice	184
sRAGE and early signs of cardiac target organ damage in mild hypertensives	184
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	183
Statins and secondary prevention of ischemic and hemorrhagic stroke	182
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	182
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	181
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	180
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	177
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	177
Statins for acute ischemic stroke	177
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	176
Is diabetes a hypercoagulable state? A critical appraisal	176
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	176
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	175
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	175
In vitro effects of Apixaban on 5 different cancer cell lines	175
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	173
Italian intersociety consensus on DOAC use in internal medicine	172
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	172
Statins, fibrates, and venous thromboembolism: a meta-analysis.	171
The role of thrombolytic therapy in pulmonary embolism	171
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	171
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	171
Prevention of in-hospital VTE: why can't we do better?	170
5 flourouracil-induced apical ballooning syndrome: a case report.	170
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	170
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	169
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	169
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	169
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	169
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	169
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	169
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	168
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	168
How I treat splanchnic vein thrombosis	168
The effect of thyroid autoantibodies on warfarin stability	168
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	168
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.	167
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect?	167
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	167
PM10 exposure is associated with increased hospitalizations for respiratory syncytial virus bronchiolitis among infants in Lombardy, Italy	166
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	165
External validation of the DASH prediction rule: a retrospective cohort study	165
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	165
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	164
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	164
Management of hypertension in overweight and obese patients: a practical guide for clinicians.	162
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	162
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis	162
Brand name versus generic warfarin: a systematic review of the literature.	161
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study	160
Totale	19.322

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	246.733
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	246.733

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4.388	0	0	0	0	0	732	291	619	838	458	574	876
2021/2022	4.033	403	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	6.685	1.049	1.000	917	1.983	1.355	381	0	0	0	0	0	0
Totale													54.490